Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University Hospital Ostrava | OTHER |
| Tomas Bata Hospital, Czech Republic | OTHER |
| General University Hospital, Prague | OTHER |
| University Hospital Hradec Kralove |
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this multicenter, observational, analytic, randomized clinical trial is to analyze the laparoscopic and robot-assisted method in the surgical treatment of patients with adrenal diseases. The main question it aims to answer are:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Initial examination 1 | Initial examination by a urologist and indication for the surgery. | 1 day |
| Initial examination 2 | Sampling of biological material: Hemoglobin g/l | 1 day |
| Surgical period 1 | Measuring the operation time in minutes. | 1 day |
| Surgical period 2 | Measuring the blood loss in milliliters (ml). | 1 day |
| Surgical period 3 | Record the need for conversion to open surgery. | 1 day |
| Surgical period 4 | Record the surgical complications. | 1 day |
| Surgical period 5 | The consumption of special surgical instruments. | 1 day |
| Perioperative period 1 | Perioperatively, the length of stay in the ICU in days. | from 3- 7 days |
| Perioperative period 2 | Perioperatively, total hospitalization time in days |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients indicated for adrenalectomy based on endocrinological and imaging examination. All patients older than 18 years who met the clinical criteria.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| MUDr. Igor Hartmann Ph.D. | Contact | +420588442895 | Igor.Hartmann@fnol.cz | |
| Natalia Wiesner | Contact | +420588445709 | natalia.wiesner@fnol.cz |
| Name | Affiliation | Role |
|---|---|---|
| MUDr. Igor Hartmann Ph.D. | Dpt. of Urology, University hospital Olomouc | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University hospital Olomouc | Recruiting | Olomouc | 77900 | Czechia |
Not provided
| OTHER |
Not provided
Not provided
Not provided
| from 3- 7 days |
| Perioperative period 3 | Perioperatively, blood loss from the drain in mililiters (ml). | from 3- 7 days |
| Perioperative period 4 | Perioperatively, time to remove the abdominal drain in days. | from 3- 7 days |
| Perioperative period 5 | Perioperatively, need for blood substitutes. | from 3- 7 days |
| Perioperative period 6 | Perioperatively, number of forced surgical revisions. | from 3- 7 days |
| Perioperative period 7 | Perioperatively, consumption of analgesics during the hospitalization. | from 3- 7 days |
| First post-operative check-up 1 | First postoperative visit (14th to 20th postoperative day), sampling of biological material: Hemoglobin g/l | 1 day of examination, 14- 20 days from the surgery |
| First post-operative check-up 2 | First postoperative visit (14th to 20th postoperative day)- an analysis of perioperative and early postoperative complications according to the Dindo Clavien classification | 1 day of examination, 14- 20 days from the surgery |
| First post-operative check-up 3 | First postoperative visit (14th to 20th postoperative day)- necessary hospitalizations and operative revisions. | 1 day of examination, 14- 20 days from the surgery |
| Second post-operative check-up 1 | Second postoperative visit (85th to 100th postoperative day)- an analysis of late postoperative complications according to the Dindo Clavien classification. | 1 day of examination, 85-100 days from the surgery |
| Second post-operative check-up 2 | Second postoperative visit (85th to 100th postoperative day)- necessary hospitalizations and operative revisions | 1 day of examination, 85-100 days from the surgery |
| ID | Term |
|---|---|
| D000310 | Adrenal Gland Neoplasms |
| D000307 | Adrenal Gland Diseases |
| D000312 | Adrenal Hyperplasia, Congenital |
| D000303 | Adrenal Cortex Diseases |
| D010673 | Pheochromocytoma |
| D003480 | Cushing Syndrome |
| D018246 | Adrenocortical Adenoma |
| D018268 | Adrenocortical Carcinoma |
| D000306 | Adrenal Cortex Neoplasms |
| ID | Term |
|---|---|
| D004701 | Endocrine Gland Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004700 | Endocrine System Diseases |
| D047808 | Adrenogenital Syndrome |
| D012734 | Disorders of Sex Development |
| D014564 | Urogenital Abnormalities |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D000013 | Congenital Abnormalities |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D030342 | Genetic Diseases, Inborn |
| D043202 | Steroid Metabolism, Inborn Errors |
| D008661 | Metabolism, Inborn Errors |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D006058 | Gonadal Disorders |
| D010235 | Paraganglioma |
| D018358 | Neuroendocrine Tumors |
| D017599 | Neuroectodermal Tumors |
| D009373 | Neoplasms, Germ Cell and Embryonal |
| D009370 | Neoplasms by Histologic Type |
| D009380 | Neoplasms, Nerve Tissue |
| D000308 | Adrenocortical Hyperfunction |
| D000230 | Adenocarcinoma |
| D002277 | Carcinoma |
| D009375 | Neoplasms, Glandular and Epithelial |
Not provided
Not provided